Page last updated: 2024-08-23

paroxetine and Agoraphobia

paroxetine has been researched along with Agoraphobia in 38 studies

Research

Studies (38)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	5 (13.16)	18.2507
2000's	22 (57.89)	29.6817
2010's	9 (23.68)	24.3611
2020's	2 (5.26)	2.80

Authors

Authors	Studies
Bianchi, L; Del Duca, E; Esposito, M; Fargnoli, MC; Giunta, A; Manfreda, V; Troisi, A	1
Gulpers, B; Hendriks, GJ; Kampman, M; Oude Voshaar, R; VAN Alphen, S; Verhey, F	1
Barbui, C; Bighelli, I; Breilmann, J; Castellazzi, M; Cipriani, A; Davies, SJ; Furukawa, TA; Girlanda, F; Guaiana, G; Koesters, M	1
Cumurcu, BE; Gul, IG; Karlidag, R; Turkoz, Y	1
Barlow, DH; Farchione, TJ; Gallagher, MW; Gorman, JM; Payne, LA; Shear, MK; White, KS; Woods, SW	1
Akiyama, K; Hirokane, G; Inoue, Y; Morita, S; Saeki, Y; Saito, A; Shimoda, K; Ueda, M; Watanabe, T; Yamada, N	1
Kim, JH; Lee, EH; Yu, BH	1
Harada, T; Ishigooka, J; Sakamoto, K; Yamada, K	1
Broekman, TG; Hendriks, GJ; Hoogduin, CA; Kampman, M; Keijsers, GP; Oude Voshaar, RC; Verbraak, MJ	1
Bandelow, B; Broocks, A; Engel, K; Neubert, K; Wedekind, D; Weiss, N	1
Amrein, R; Crippa, JA; da Costa, RT; de Carvalho, MR; de Cerqueira, AC; de O E Silva, AC; de-Melo-Neto, VL; Dias, GP; Freire, RC; Hallak, JE; King, AL; Levitan, MN; Mezzasalma, MA; Mochcovitch, MD; Nardi, AE; Nascimento, I; Sardinha, A; Soares-Filho, GL; Valença, AM; Veras, AB; Versiani, M	1
Hendriks, GJ; Hoogduin, CA; Kampman, M; Keijsers, GP; Oude Voshaar, RC	1
Cassano, GB; Mula, M; Pini, S; Preve, M	1
Kollias, K; Konstantakopoulos, G; Nathanailidis, E; Oulis, P; Tsiamoura, M	1
Hendriks, GJ; Hoogduin, CA; Kampman, M; Keijsers, GP	1
Cowley, DS; Katon, WJ; Roy-Byrne, PP; Russo, J	1
Koga, M	1
Mao, CG; Sheehan, DV	1
Cohen, A; Dannon, PN; Grunhaus, L; Iancu, I; Kotler, M; Lowengrub, K	1
Chao, I	1
Baldwin, DS; Bradley, BP; Brodrick, P; Mogg, K	1
Griez, E; Schruers, K	1
Espa-Cervená, K; Houbová, P; Novák, T; Pasková, B; Prasko, J; Vyskocilová, J; Záleský, R	1
Campanella, D; Carano, A; Cicconetti, A; D'Amico, M; De Berardis, D; Ferro, FM; Gambi, F; La Rovere, R; Mancini, E; Peca, S; Penna, L; Salerno, RM; Sepede, G	1
Cantoni, A; Fontò, S; Giannelli, MR; Maggini, C; Marchesi, C	1
Emilien, G; Gao, B; Koponen, H; Lepola, U; Pollack, MH; Salinas, E; Simon, NM; Tzanis, E; Whitaker, T; Worthington, JJ	1
Agius, M; Biocina-Martić, S; Dordević, V; Gruber, EN	1
Doruk, A; Gulsun, M; Ozsahin, A; Turkbay, T; Uzun, O	1
Iny, L; Luthe, L; Pecknold, JC; Ramdoyal, D	1
Power, KG; Sharp, DM; Simpson, RJ	1
Ballenger, JC; Bushnell, W; Gergel, IP; Steiner, M; Wheadon, DE	1
Allgulander, C; Brandt, L; Cloninger, CR; Przybeck, TR	1
Bakker, A; Spinhoven, P; van Balkom, AJ; van Dyck, R	1
González, E; Minguez, L; Sanguino, RM	1
Akiskal, HS; Frare, F; Mata, B; Mengali, F; Perugi, G; Recchia, M; Serra, G; Toni, C; Vitale, B	1
Andriushchenko, AV; Bykov, SI; Grigor'evskikh, VS; Koliutskaia, EV; Kosinskiĭ, VP; Kostiukova, EG; Kozlovskiĭ, VL; Kuzavkova, MV; Mosolov, SN; Nuller, IuL; Pererva, IG; Smulevich, AB; Zelenina, EV	1
di Michele, F; Holsboer, F; Pasini, A; Romeo, E; Rupprecht, R; Ströhle, A; Yassouridis, A	1
Adrover, M; Argyropoulos, S; Bell, C; Forshall, S; Hood, S; Nash, J; Nutt, DJ; Rich, A	1

Reviews

3 review(s) available for paroxetine and Agoraphobia

Article	Year
Benzodiazepines versus placebo for panic disorder in adults. The Cochrane database of systematic reviews, 2019, Mar-28, Volume: 3 Topics: Adult; Aged; Agoraphobia; Benzodiazepines; Buspirone; Humans; Imipramine; Middle Aged; Numbers Needed To Treat; Panic Disorder; Paroxetine; Patient Dropouts; Placebos; Propranolol; Randomized Controlled Trials as Topic; Remission Induction; Young Adult	2019
[Panic disorder and agoraphobia]. Ryoikibetsu shokogun shirizu, 2003, Issue:38 Topics: Agoraphobia; Cognitive Behavioral Therapy; Diagnosis, Differential; Diagnostic and Statistical Manual of Mental Disorders; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Reference Standards; Selective Serotonin Reuptake Inhibitors	2003
Paroxetine treatment of generalized anxiety disorder. Psychopharmacology bulletin, 2003,Spring, Volume: 37 Suppl 1 Topics: Agoraphobia; Antidepressive Agents, Second-Generation; Humans; Paroxetine; Secondary Prevention	2003

Trials

22 trial(s) available for paroxetine and Agoraphobia

Article	Year
The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder. Journal of psychiatric practice, 2020, Volume: 26, Issue:3 Topics: Adolescent; Adult; Aged; Agoraphobia; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality; Personality Disorders; Treatment Outcome; Young Adult	2020
SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL. Depression and anxiety, 2016, Volume: 33, Issue:5 Topics: Adult; Agoraphobia; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2016
A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder. Acta psychiatrica Scandinavica, 2010, Volume: 122, Issue:1 Topics: Aged; Agoraphobia; Cognitive Behavioral Therapy; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	2010
A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder. The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:7 Topics: Adult; Agoraphobia; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Pilot Projects; Relaxation Therapy; Running; Selective Serotonin Reuptake Inhibitors; Young Adult	2010
Psychopharmacotherapy of panic disorder: 8-week randomized trial with clonazepam and paroxetine. Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2011, Volume: 44, Issue:4 Topics: Adolescent; Adult; Agoraphobia; Clonazepam; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Treatment Outcome; Young Adult	2011
Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:2 Topics: Age Factors; Age of Onset; Aged; Agoraphobia; Cognitive Behavioral Therapy; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Predictive Value of Tests; Regression Analysis; Selective Serotonin Reuptake Inhibitors	2012
A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone. The Journal of clinical psychiatry, 2002, Volume: 63, Issue:9 Topics: Agoraphobia; Cognitive Behavioral Therapy; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Humans; Panic Disorder; Paroxetine; Personality Inventory; Placebos; Selective Serotonin Reuptake Inhibitors; Surveys and Questionnaires; Treatment Outcome	2002
Unemployment and emergency room visits predict poor treatment outcome in primary care panic disorder. The Journal of clinical psychiatry, 2003, Volume: 64, Issue:4 Topics: Adult; Agoraphobia; Comorbidity; Emergency Services, Psychiatric; Female; Follow-Up Studies; Health Status; Humans; Income; Male; Middle Aged; Multivariate Analysis; Panic Disorder; Paroxetine; Patient Education as Topic; Primary Health Care; Probability; Regression Analysis; Severity of Illness Index; Social Class; Treatment Outcome; Unemployment; White People	2003
Three year naturalistic outcome study of panic disorder patients treated with paroxetine. BMC psychiatry, 2004, Jun-11, Volume: 4 Topics: Adult; Agoraphobia; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Obesity; Panic Disorder; Paroxetine; Prevalence; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunctions, Psychological; Treatment Outcome; Weight Gain	2004
Effect of short-term SSRI treatment on cognitive bias in generalised anxiety disorder. Psychopharmacology, 2004, Volume: 176, Issue:3-4 Topics: Adult; Affect; Agoraphobia; Citalopram; Cognition; Cross-Sectional Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Psychomotor Performance; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2004
The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder. Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:4 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Carbon Dioxide; Comorbidity; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Compliance; Thiazepines	2004
Influence of personality disorder on the treatment of panic disorder--comparison study. Neuro endocrinology letters, 2005, Volume: 26, Issue:6 Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Disorders; Personality Inventory; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors	2005
Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:1 Topics: Adult; Agoraphobia; Antipsychotic Agents; Benzodiazepines; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure	2006
A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Depression and anxiety, 2007, Volume: 24, Issue:1 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Quality of Life; Treatment Outcome; Venlafaxine Hydrochloride	2007
Fluoxetine in panic disorder: pharmacologic and tritiated platelet imipramine and paroxetine binding study. Journal of psychiatry & neuroscience : JPN, 1995, Volume: 20, Issue:3 Topics: Adolescent; Adult; Agoraphobia; Female; Fluoxetine; Humans; Imipramine; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Prospective Studies; Psychiatric Status Rating Scales	1995
Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. The American journal of psychiatry, 1998, Volume: 155, Issue:1 Topics: Adult; Agoraphobia; Comorbidity; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome	1998
Changes on the Temperament and Character Inventory after paroxetine treatment in volunteers with generalized anxiety disorder. Psychopharmacology bulletin, 1998, Volume: 34, Issue:2 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Character; Humans; Paroxetine; Psychiatric Status Rating Scales; Temperament	1998
Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:12 Topics: Adolescent; Adult; Aged; Agoraphobia; Clomipramine; Cognitive Behavioral Therapy; Comorbidity; Double-Blind Method; Female; Humans; Male; Medical Records; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome	1999
A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants. Pharmacopsychiatry, 2000, Volume: 33, Issue:4 Topics: Adult; Aged; Agoraphobia; Antidepressive Agents; Clomipramine; Demography; Female; Humans; Imipramine; Italy; Longitudinal Studies; Male; Middle Aged; Panic Disorder; Paroxetine; Patient Dropouts; Probability; Prospective Studies; Time Factors; Treatment Outcome	2000
[Clinical effect and tolerance of paxil (paroxetine) in management of panic disorders]. Terapevticheskii arkhiv, 2000, Volume: 72, Issue:10 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Female; Humans; Male; Panic Disorder; Paroxetine; Treatment Outcome	2000
GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. The American journal of psychiatry, 2002, Volume: 159, Issue:1 Topics: Adult; Agoraphobia; Female; Follow-Up Studies; GABA-A Receptor Antagonists; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Pregnanolone; Receptors, GABA-A; Stereoisomerism; Treatment Outcome	2002
Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine. Journal of psychopharmacology (Oxford, England), 2002, Volume: 16, Issue:1 Topics: Adult; Affect; Aged; Agoraphobia; Cross-Over Studies; Double-Blind Method; Female; Flumazenil; GABA Modulators; Hemodynamics; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Tryptophan	2002

Other Studies

13 other study(ies) available for paroxetine and Agoraphobia

Article	Year
Long-term safety and efficacy of secukinumab in patients with psoriasis and major psychiatric disorders: a case series. Postgraduate medicine, 2020, Volume: 132, Issue:2 Topics: Adult; Agoraphobia; Antibodies, Monoclonal, Humanized; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder; Depressive Disorder, Major; Female; Humans; Lithium Carbonate; Male; Mental Disorders; Middle Aged; Nordazepam; Panic Disorder; Paroxetine; Psoriasis; Quetiapine Fumarate; Severity of Illness Index; Treatment Outcome; Valproic Acid	2020
Ghrelin and lipid levels in panic disorder before and after treatment and their relationship with agoraphobia. Psychiatria Danubina, 2015, Volume: 27, Issue:3 Topics: Agoraphobia; Ghrelin; Humans; Lipids; Panic Disorder; Paroxetine	2015
Genetic and pharmacokinetic factors affecting the initial pharmacotherapeutic effect of paroxetine in Japanese patients with panic disorder. European journal of clinical pharmacology, 2009, Volume: 65, Issue:7 Topics: Adult; Aged; Agoraphobia; Antidepressive Agents, Second-Generation; Asian People; Female; Genotype; Humans; Japan; Linear Models; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Serotonin Plasma Membrane Transport Proteins; Severity of Illness Index; Time Factors; Young Adult	2009
Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea. Depression and anxiety, 2009, Volume: 26, Issue:8 Topics: Adult; Aged; Agoraphobia; Antidepressive Agents, Second-Generation; Cross-Cultural Comparison; Female; Humans; Korea; Male; Middle Aged; Panic Disorder; Paroxetine; Personality Inventory; Psychometrics; Reproducibility of Results; Translating; Young Adult	2009
Aripiprazole augmentation for a patient with partial remission of panic disorder. Journal of clinical psychopharmacology, 2009, Volume: 29, Issue:3 Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Humans; Male; Panic Disorder; Paroxetine; Piperazines; Quinolones; Remission Induction; Selective Serotonin Reuptake Inhibitors; Treatment Outcome	2009
Venlafaxine in somatopsychic and autopsychic depersonalization. Progress in neuro-psychopharmacology & biological psychiatry, 2011, Dec-01, Volume: 35, Issue:8 Topics: Agoraphobia; Cyclohexanols; Depersonalization; Depressive Disorder; Humans; Male; Obsessive Behavior; Panic Disorder; Paroxetine; Retreatment; Selective Serotonin Reuptake Inhibitors; Trimipramine; Venlafaxine Hydrochloride; Young Adult	2011
Low-dose aripiprazole in the treatment of selective serotonin reuptake inhibitors-induced orofacial and buccal dystonia. Psychiatry and clinical neurosciences, 2012, Volume: 66, Issue:5 Topics: Adult; Agoraphobia; Antipsychotic Agents; Aripiprazole; Dystonia; Face; Female; Humans; Panic Disorder; Paroxetine; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors	2012
Olanzapine augmentation in panic disorder: a case report. Pharmacopsychiatry, 2004, Volume: 37, Issue:5 Topics: Agoraphobia; Benzodiazepines; Drug Synergism; Drug Therapy, Combination; Humans; Male; Middle Aged; Olanzapine; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2004
Predictors of symptom resolution in panic disorder after one year of pharmacological treatment: a naturalistic study. Pharmacopsychiatry, 2006, Volume: 39, Issue:2 Topics: Adult; Agoraphobia; Anxiety Disorders; Citalopram; Diagnostic and Statistical Manual of Mental Disorders; Female; Follow-Up Studies; Humans; Male; Panic Disorder; Paroxetine; Prospective Studies; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index	2006
"My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis. Psychiatria Danubina, 2006, Volume: 18, Issue:3-4 Topics: Adult; Agoraphobia; Antipsychotic Agents; Atenolol; Benzodiazepines; Cognitive Behavioral Therapy; Combined Modality Therapy; Desensitization, Psychologic; Diazepam; Hospitalization; Humans; Male; Olanzapine; Panic Disorder; Paroxetine; Psychotic Disorders; Reality Testing; Socialization	2006
Effect of dissociative experiences on drug treatment of panic disorder. Clinical drug investigation, 2007, Volume: 27, Issue:8 Topics: Adult; Agoraphobia; Dissociative Disorders; Female; Humans; Male; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Regression Analysis; Selective Serotonin Reuptake Inhibitors	2007
Five group comparisons of treatments for anxiety disorders. The British journal of psychiatry : the journal of mental science, 1995, Volume: 167, Issue:6 Topics: Agoraphobia; Controlled Clinical Trials as Topic; Humans; Panic Disorder; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors	1995
Galactorrhea after paroxetine treatment. Pharmacopsychiatry, 2000, Volume: 33, Issue:3 Topics: Adult; Agoraphobia; Antidepressive Agents, Second-Generation; Female; Galactorrhea; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors	2000